Life Science
Incubator Leiden

Fireside Chat – Prothya Biosolutions

During these talks, we ask experienced and successful Life Science entrepreneurs to come and share their experiences with the up-and-coming entrepreneurs in the unlock_ community.

The Fireside Chats are a great way to ask questions and hear personal experiences from successful Life Science entrepreneurs.

This event is open to all life science and biotech startups in the Leiden Bio Science Park community.

Join us on November 10 with Chris Lamb from Prothya Biosolutions.

  • Date: 10-11-2022
  • Time: 14:00 – 16:00
  • Location: Startup Zone, BioPartner 5  De Limes 7, 2342 DH Oegstgeest

Sign up here!

About the speaker

Chris Lamb is the Chief Executive Officer, board member and investor of Prothya Biosolutions. He has over 35 years of experience in the biotherapeutics and biotechnology industry, including the American Red Cross where he served as the COO for the Blood Plasma Division, and as board member and serial entrepreneur for startups in the US, China, Europe, and Israel . Chris has a PhD degree in Management from Case Western Reserve University and has served as an Adjunct Professor for undergraduate and graduate business students.

About Prothya Biosolutions

Prothya Biosolutions is a global biopharmaceutical company specialized in the production of plasma-derived medicines. In addition, the company collects, tests and supplies blood plasma intermediates to numerous companies in the industry around the world (Specialty Services). Prothya Biosolutions has several offices, production locations and plasma centers in the Netherlands, Belgium, Finland, Hungary, and the US and collectively employs around 1200 people. The company’s mission: to create value for our partners and contribute to sustaining the health of those who depend on essential plasma derived medicines. In short: Creating Value, Sustaining Life.

Prothya Biosolutions was formed in 2021, when Plasma Industries Belgium (PIBe), with roots in the Belgian Red Cross, integrated with Sanquin Plasma Products, a former subsidiary of the Sanquin Blood Supply Foundation. Prothya Biosolutions offers over 60 years of experience in the collection of blood plasma and production of plasma-derived medicinal products, and a long legacy of collaboration, innovation, and delivery of science-based solutions.